Kathryn Beldowski, MD
Geriatric Medicine · Broomall, PANPI 1487947487
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,096 and has fallen 67.5% since, to $356 in 2025. Among geriatric medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 178 payments — averaging $20.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$464
- Novo Nordisk$331
- Teva Pharmaceuticals USA, Inc.$293
- Otsuka America Pharmaceutical, Inc.$287
- Novartis$232
- GSK$213
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,608100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 25 | $464 |
| Novo Nordisk | 18 | $331 |
| Teva Pharmaceuticals USA, Inc. | 16 | $293 |
| Otsuka America Pharmaceutical, Inc. | 14 | $287 |
| Novartis | 13 | $232 |
| GSK | 9 | $213 |
| Johnson & Johnson | 9 | $173 |
| Eisai Inc. | 5 | $140 |
| Sumitomo Pharma America, Inc. | 8 | $139 |
| Avanir Pharmaceuticals, Inc. | 4 | $134 |
| AbbVie | 6 | $115 |
| Acadia Pharmaceuticals Inc | 6 | $109 |
| Bayer | 5 | $107 |
| Pfizer | 6 | $99 |
| Neurocrine Biosciences, Inc. | 4 | $94 |
| Biogen | 3 | $89 |
| Amgen | 4 | $82 |
| UCB, Inc. | 3 | $79 |
| Lundbeck LLC | 4 | $78 |
| AstraZeneca | 4 | $68 |
| Xeris Pharmaceuticals, Inc. | 2 | $56 |
| Dexcom, Inc. | 1 | $48 |
| E.r. Squibb & Sons, L.L.C. | 2 | $44 |
| Exact Sciences | 1 | $32 |
| Inari Medical, Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
How this compares
$3,613 in reported general payments places this provider in the 90th percentile of 217 geriatric medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 283 | $121,940 |
| JardianceEmpagliflozin | 130 | $71,395 |
| OzempicSemaglutide | 58 | $69,266 |
| TrulicityDulaglutide | 49 | $52,701 |
| XareltoRivaroxaban | 110 | $44,844 |
| JanuviaSitagliptin Phosphate | 87 | $44,574 |
| MounjaroTirzepatide | 25 | $28,495 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $26,070 |
| NuplazidPimavanserin Tartrate | 11 | $25,893 |
| MyrbetriqMirabegron | 102 | $23,867 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 68 | $21,501 |
| Nurtec OdtRimegepant Sulfate | 19 | $20,154 |
| LinzessLinaclotide | 32 | $18,376 |
| Atorvastatin Calcium | 877 | $13,983 |
| Paliperidone ErPaliperidone | 21 | $13,845 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo, Nurtec Odt | $99 | $163,595370 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Olanzapine | $464 | $87,509209 claims |
| Boehringer IngelheimJardiance | $15 | $71,395130 claims |
| Novo NordiskOzempic | $331 | $69,26658 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $213 | $46,08182 claims |
| Johnson & JohnsonXarelto | $173 | $44,844110 claims |
| Acadia Pharmaceuticals IncNuplazid | $109 | $25,89311 claims |
| Astellas Pharma US IncMyrbetriq | $20 | $23,867102 claims |
| AbbVieLinzess, Restasis | $115 | $23,67243 claims |
| AstraZenecaFarxiga, Lokelma | $68 | $20,57270 claims |
| NovartisEntresto | $232 | $13,72646 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $139 | $10,84429 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 217 geriatric medicine providers in Pennsylvania.
Other geriatric medicine in Broomall
- Christopher HwangBroomall$4K
- Richard StefanacciPhiladelphia$146K
- James LinErie$73K
- Adele TowersPittsburgh$29K
- Michele ZaworaPhiladelphia$21K
- Daniel HaimowitzLevittown$15K
- Robert PearlsteinPlymouth Meeting$15K
- Seth CarterErie$14K
- Moushumi KunduHanover$12K
- Jason KarlawishPhiladelphia$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.